OOIR: Observatory of International Research

Papers

(The median citation count of International Clinical Psychopharmacology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	37
The role of personality traits in following quarantine orders during the COVID-19 pandemic	33
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	19
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	18
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	15
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	14
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	14
Antidepressant psychopharmacology: is inflammation a future target?	14
Clinical specificity profile for novel rapid acting antidepressant drugs	14
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	14
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	12
Open issues in bipolar and antipsychotic treatments	11
Case series on aripiprazole and dopamine supersensitivity psychosis	11
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	10
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	10
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	10
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	10
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	10
Managing depression in the elderly: real-world clinical considerations and perspectives	10
Debated issues in major psychoses	10
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	9
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	9
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	9
The Gordian knot of the immune-redox systems’ interactions in psychosis	9
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	9

The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	9
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	9
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	8
Modulating factors in mood disorders treatment	8
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	8
Innovation in psychopharmacology	8
Elevated liver transaminases among patients with psychiatric disorders	8
Suicide behind bars: time to tackle barriers to mental healthcare access in prisons	8
Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders	8
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis	7
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	7
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	7
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	7
Case report and systematic review of cerebellar vermis alterations in psychosis	7
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	6
Interplay of environmental and clinical factors in psychiatric disorders	6
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	6
Manic episode in a patient with pancreatic adenocarcinoma: a case report	6
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	6
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	6
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	6
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland	6
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	6
Allergic reaction induced by subcutaneous administration of ketamine: a case report	6
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	6
Advances in the treatment of depression	6
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	5
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences	5
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	5
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features	5
The challenge of managing difficult to treat psychiatric conditions	5
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	5
Persian translation and validation of community attitudes toward the mentally ill scale: a tool for assessing social stigma about mental illness	5
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	5
Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms	4
Pharmacological and philosophical considerations for the around-the-clock use of scheduled melatonin to promote sedation and reduce aggression in individuals with serious mental illness: a case report	4
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence	4
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?	4
Psychometric validation of the Persian version of the Mental Health Knowledge Schedule	4
The effect of early or late initiation of long-acting antipsychotics on the caregiver burden in schizophrenia	4
An investigation into the association between suicide mortality rate and lithium levels in potable water: a review study	4
Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation	4
Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis	4
Aripiprazole: examining the clinical implications of D2 affinity	4
In search of clinical targets for suicide prevention in major depressive disorder	4
Frequency, risk factors, and impacts on quality of life of the restless legs syndrome and side effects among antidepressant users in a tertiary hospital: an observational cross-sectional study	4
Evaluating the influence of nonproblematic alcohol intake on the outcome of major depression	4
Diabetes mellitus in patients with chronic bipolar disorder: prevalence, clinical correlates and relationship with homocysteine	4
The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial	4
Clinical and demographic factors associated with early relapse in patients with schizophrenia: a naturalistic observation study	4

Efficacy and safety of adjunctive therapy with lumateperone in major depressive disorder: a randomized-, double-blind, placebo-controlled clinical trial	4
Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study	4
Does tramadol dependence impair cognitive functions?	4
Crocus sativus (saffron) adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled trial	4
Unleashing the power of pooled and subgroup analyses in psychiatry	3
Catatonic postpartum paternal depression as a first debut of a bipolar disorder: a case report	3
Psychopharmacology: past, present and future	3
Short-term, but not long-term, beneficial effects of concomitant benzodiazepine use on clinical course in patients with schizophrenia	3
Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient	3
Resistance to antidepressant treatment among patients with major depressive disorder: a nationwide study	3
Can bupropion treat COVID-19–induced brain fog? A case series	3
Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis	3
Successful clozapine rechallenge after myopericarditis: a case report	3
Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder	3
Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations	3
Associations of adolescent psychosocial factors to later benzodiazepine use: a population-based follow-up study of adolescent psychiatric inpatients in Northern Finland	3
Antidepressant treatment in complex clinical pictures	3
Brexpiprazole augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary retrospective observational study	3
Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis	3
Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort	3
Can levetiracetam improve clinical symptoms in schizophrenic patients? A randomized placebo-controlled clinical trial	3
Severe methodological problems in a recent review and analysis of the association between lithium concentration in potable water and suicide rates	3
Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial	3
Dissociative episode and panic attacks triggered by pitolisant in a narcoleptic patient	3
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder	3
Medicare claims analysis of agents used to manage dementia-related psychosis: a treatment pattern study	3
Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report	3
Characteristics and outcomes of cases with methylphenidate abuse, dependence or withdrawal: an analysis of spontaneous reports in EudraVigilance	3
Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis	3
Oxcarbazepine versus sodium valproate in treatment of acute mania: a double-blind randomized clinical trial	3
An algorithmic approach to the case management of patients diagnosed with schizophrenia and substance use disorders: what is the evidence?	3
Agranulocytosis after long-term clozapine use: a case report	3
Type 2 diabetes mellitus is associated with manic morbidity in elderly patients with mood disorders	2
More must be done to reduce cardiovascular risk for patients on antipsychotic medications	2
Pharmacologic treatment of depression in Alzheimer’s disease	2
l-carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial	2
Sex-specific clinical characteristics and treatment responses in delirium management: findings from a prospective cohort study in elderly patients	2
Olanzapine intramuscular shows better efficacy than zuclopenthixol acetate intramuscular in reducing the need for restraint, but not in comparison to haloperidol intramuscular	2
Risk of corrected QT interval prolongation in patients receiving antipsychotics	2
Ketamine for depression: a potential role in requests for Medical Aid in Dying?	2
Examining age of onset phenotype in the spectrum of mood disorders	2
Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder	2
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol	2
Risperidone as an adjuvant treatment for obsessive-compulsive symptoms in patients with bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial	2
Safety and efficacy of daridorexant in the treatment of insomnia: a systematic review and meta-analysis of randomized controlled trials	2
Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality	2
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry	2
Understanding mood disorder treatments	2
The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?	2
Relationship between clinical efficacy and plasma concentration-dose ratio of risperidone in patients with schizophrenia	2
Raising awareness for adult ADHD diagnosis: addressing diagnostic challenges, comorbidities, and the path to proper recognition	2
Antidepressants use in Italy: an ecological study of national and regional trends and associated factors	2
Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report	2
Investigating the psychological effects of home quarantine during the early peaks of the COVID-19 pandemic: a survey from Iran	2
Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study	2
DRESS syndrome: quetiapine associated case report and literature review	2
Levetiracetam adjunct to quetiapine for the acute manic phase of bipolar disorder: a randomized, double-blind and placebo-controlled clinical trial of efficacy, safety and tolerability	2
Lamotrigine-induced mania: warning report for the identification of vulnerable populations and expert clinical recommendations for prescription	2
Efficacy, suicidality, tolerability, and acceptability of selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors for children and adolescents with anxiety disorders:	2
Risk of conversion to bipolar disorder in patients with late-onset major depression	2
Safety and tolerability of cariprazine for the adjunctive treatment of major depressive disorder: a pooled analysis of phase 2b/phase 3 clinical trials	2
Lurasidone as add-on to fluoxetine in obsessive-compulsive disorder with comorbid restrictive anorexia: a case report	2
Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report	2